Literature DB >> 7252957

Salivary and urine theophylline levels in management of childhood asthma.

S J Goldsworthy, M Kemp, J O Warner.   

Abstract

It is not possible to predict the plasma theophylline levels that can be achieved using slow-release aminophylline based on body weight or surface area. Improvement in FEV1 is directly related to increasing serum theophylline level, justifying the need for measuring levels in order to optimize therapy. As repeated venesection in children is unpleasant we have studied a simple method using saliva. Simultaneous blood and salivary theophylline levels correlated sufficiently well for salivary levels to be used for monitoring purposes. Urine levels did not correlate as well, but could be used for checking compliance.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7252957      PMCID: PMC1438782          DOI: 10.1177/014107688107400604

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  10 in total

1.  Dosage of theophylline in bronchial asthma.

Authors:  K M Piafsky; R I Ogilvie
Journal:  N Engl J Med       Date:  1975-06-05       Impact factor: 91.245

2.  Study of theophylline plasma levels after oral administration of new theophylline compounds.

Authors:  M TURNER-WARWICK
Journal:  Br Med J       Date:  1957-07-13

3.  Reliability of salivary theophylline as a guide to plasma theophylline levels.

Authors:  S P Galant; S A Gillman; L H Cummins; P P Kozak; J J Orcutt
Journal:  Am J Dis Child       Date:  1977-09

4.  Evaluation of oral bronchodilator therapy in asthmatic children. Bronchodilators in asthmatic children.

Authors:  M M Weinberger; E A Bronsky
Journal:  J Pediatr       Date:  1974-03       Impact factor: 4.406

5.  Dose of theophylline for asthma.

Authors:  M Weinberger; L Hendeles
Journal:  J Pediatr       Date:  1978-09       Impact factor: 4.406

6.  Serum theophylline levels in asthmatic children after oral administration of two slow-release theophylline preparations.

Authors:  S McKenzie; E Baillie
Journal:  Arch Dis Child       Date:  1978-12       Impact factor: 3.791

7.  Assay of theophylline: comparison of EMIT on the ABA-100 to HPLC, GLC and UV procedures, with detailed evaluation of interferences.

Authors:  N Weidner; J M McDonald; V L Tieber; C H Smith; G Kessler; J H Ladenson; D N Dietzler
Journal:  Clin Chim Acta       Date:  1979-09-15       Impact factor: 3.786

8.  Guide to oral theophylline therapy for the treatment of chronic asthma.

Authors:  L Hendeles; M Weinberger; R Wyatt
Journal:  Am J Dis Child       Date:  1978-09

9.  Salivary theophylline estimation in the management of asthma in children.

Authors:  S M Lena; P Hutchins; C B Wood; P Turner
Journal:  Postgrad Med J       Date:  1980-02       Impact factor: 2.401

10.  A method for obtaining saliva samples from infants and young children.

Authors:  C J Bacon; J C Mucklow; A Saunders; M D Rawlins; J K Webb
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

  10 in total
  2 in total

1.  Do saliva concentrations predict plasma unbound theophylline concentrations? A problem re-examined.

Authors:  C Knott; M Bateman; F Reynolds
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

2.  Reproducibility of saliva and plasma theophylline levels following single dose administration of two sustained release preparations.

Authors:  A H Jackson; C Edwards; A S Cope; R A Stockley; R Purkiss
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.